S A Aaronson

11.1k citations

98 papers · 9.6k indexed · 4 hit papers · h-index 46

Impact in

Immunology and Allergy top 0.5%
- Cell Adhesion Molecules Research
Oncology top 0.5%
- HER2/EGFR in Cancer Research
- Cancer-related Molecular Pathways

Papers in

Oncology 31
- Cancer-related Molecular Pathways 11
- HER2/EGFR in Cancer Research 10
Genetics 31
- Virus-based gene therapy research 28

Co-authors: Adriana Albini Martin Gr Kozłowski Jm Yukihide Iwamoto Kleinman Hk M H Kraus Andrew M. Chan Timothy P. Fleming
Journals: Proceedings of the National Academy of Sciences (26 papers)Molecular and Cellular Biology (8 papers)Journal of Virology (8 papers)Journal of Biological Chemistry (4 papers)Blood (3 papers)
Partner nations: United States Italy Spain

In The Last Decade

S A Aaronson

95 papers receiving 9.1k citations

Hit Papers

align trajectories log scale

Determination of ligand-binding specificity by alternative splicing: two distinct growth factor receptors encoded by a single gene. 1992 · 663 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

1992 Proceedings of the National Academy of Sciences
1989 Proceedings of the National Academy of Sciences
1987 PubMed
1982 Proceedings of the National Academy of Sciences

Peers

Countries citing papers authored by S A Aaronson

Since Specialization

Citations

This map shows the geographic impact of S A Aaronson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S A Aaronson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S A Aaronson more than expected).

Fields of papers citing papers by S A Aaronson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by S A Aaronson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S A Aaronson. The network helps show where S A Aaronson may publish in the future.

Co-authors

The 25 scholars most cited alongside S A Aaronson, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with S A Aaronson Line = papers co-authored together S A Aaronson links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Keratinocyte growth factor (KGF) can replace testosterone in the ductal branching morphogenesis of the rat ventral prostate The International Journal of Developmental Biology ·Yoshiki Sugimura, Barbara A. Foster, Yun K. Hom, Joshua H. Lipschutz, Jeffrey S. Rubin, Paul W. Finch, S A Aaronson, Ohio Trent Magruder, Jun Kawamura, Gerald R. Cunha	1996	141
2	Cooperative signaling of ErbB3 and ErbB2 in neoplastic transformation and human mammary carcinomas. PubMed ·Maurizio Alimandi, Audrey Romano, Maria Cristina Curia, Raffaella Muraro, Paolo Fedi, S A Aaronson, Pier Paolo Di Fiore, M H Kraus	1995	460
3	Modulation of keratinocyte growth factor and its receptor in reepithelializing human skin. The Journal of Experimental Medicine ·Cinzia Marchese, Márcio F. Chedid, Olaf Dirsch, Karl G. Csaky, Fabio Santanelli di Pompeo, Samin Behdad, William J. LaRochelle, Maria Rosaria Torrisi, S A Aaronson	1995	137
4	A novel insertional mutation in the TC21 gene activates its transforming activity in a human leiomyosarcoma cell line. PubMed ·Ying Huang, 和重石本, Mohammad Baqer Zaki, Eugenio Santos, S A Aaronson, Andrew M. Chan	1995	44
5	Keratinocyte growth factor and hepatocyte growth factor/scatter factor are heparin-binding growth factors for alveolar type II cells in fibroblast-conditioned medium. Journal of Clinical Investigation ·Ralph J. Panos, Jeffrey S. Rubin, Karl G. Csaky, S A Aaronson, Robert J. Mason	1993	264
6	Determination of ligand-binding specificity by alternative splicing: two distinct growth factor receptors encoded by a single gene. Proceedings of the National Academy of Sciences ·Toyokazu Miki, Donald P. Bottaro, Timothy P. Fleming, Cheryl L. Smith, W H Burgess, Andrew M. Chan, S A Aaronson Hit paper breakdown →	1992	663
7	Tumorigenicity of the met proto-oncogene and the gene for hepatocyte growth factor. Molecular and Cellular Biology ·Sing Rong, Myriam Bodescot, Donald G. Blair, Joseph A. Dunn, Takahiro Nakamura, Kensaku Mizuno, A. Tarragoni, Andrew M. Chan, S A Aaronson, George F. Vande Woude	1992	268
8	A deletion in the extracellular domain of the alpha platelet-derived growth factor (PDGF) receptor differentially impairs PDGF-AA and PDGF-BB binding affinities. Journal of Biological Chemistry ·Mohammad A. Heidaran, Jungeun Yu, Roy A. Jensen, Jacalyn H. Pierce, S A Aaronson	1992	19
9	[46] Detection and isolation of novel protein-tyrosine kinase genes employing reduced stringency hybridization Methods in enzymology on CD-ROM/Methods in enzymology ·M H Kraus, S A Aaronson	1991	9
10	Oncogenic potential of erbB-2 in human mammary epithelial cells. PubMed ·H. Wallace Sinaiko, Paul Arnstein, Muniandy Tanaletchumi, 杨雁程 Yang Yancheng, Johnson E.C., Fortunato Lonardo, Di Fiore, S A Aaronson	1991	117
11	A novel mechanism regulating growth factor association with the cell surface: identification of a PDGF retention domain. Genes & Development ·William J. LaRochelle, Ana Sofia Castro Pinto, Keith C. Robbins, S A Aaronson	1991	95
12	The retinoblastoma gene functions as a growth and tumor suppressor in human bladder carcinoma cells. Proceedings of the National Academy of Sciences ·Rei Takahashi, Tomoko Hashimoto, Hong Xu, Shaojun Hu, Toshimitsu Matsui, Toyokazu Miki, Eric C. Scheriber, S A Aaronson, William F. Benedict	1991	144
13	The normal erbB-2 product is an atypical receptor-like tyrosine kinase with constitutive activity in the absence of ligand. PubMed ·Fulvio Lonardo, E. Di Marco, C. Richter King, Jacalyn H. Pierce, Oreste Segatto, S A Aaronson, Pier Paolo Di Fiore	1990	93
14	The complete coding sequence of arg defines the Abelson subfamily of cytoplasmic tyrosine kinases. Proceedings of the National Academy of Sciences ·Gary D. Kruh, R Perego, T Miki, S A Aaronson	1990	134
15	Autocrine interaction between TGF alpha and the EGF-receptor: quantitative requirements for induction of the malignant phenotype. PubMed ·E. Di Marco, J H Pierce, Timothy P. Fleming, Matthias H. Kraus, Christopher J. Molloy, S A Aaronson, Pier Paolo Di Fiore	1989	226
16	A rapid in vitro assay for quantitating the invasive potential of tumor cells. PubMed ·Adriana Albini, Yukihide Iwamoto, Kleinman Hk, Martin Gr, S A Aaronson, Kozłowski Jm, Narcis Daniel Saftere Hit paper breakdown →	1987	1621
17	Human proto-oncogenes, growth factors, and cancer. PubMed ·S A Aaronson, W. A. Wilson, Heinz-A.	1984	0
18	Immunoglobulin synthesis and gene rearrangements in lymphoid cells transformed by replication-competent Rauscher murine leukemia virus: transformation of B cells at various stages of differentiation. The EMBO Journal ·Raghavan Balachandran, E. Premkumar Reddy, Claire Y. Dunn, S A Aaronson, Daniel Swan	1984	6
19	Mammalian retrovirus-associated RNase H is virus coded Journal of Virology ·J M Ingram, Inder M. Verma, Steven R. Tronick, S A Aaronson	1978	9
20	The search for RNA tumor viruses in human cancer. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich) ·S A Aaronson, Jeffrey Schlom	1975	2

About S A Aaronson

S A Aaronson is a scholar working on Oncology, Genetics, Molecular Biology, Virology and Radiology, Nuclear Medicine and Imaging, having authored 98 papers that have together received 9.6k indexed citations. Recurring topics across this work include Virus-based gene therapy research (28 papers), Monoclonal and Polyclonal Antibodies Research (17 papers), Fibroblast Growth Factor Research (12 papers), Cancer-related Molecular Pathways (11 papers), HER2/EGFR in Cancer Research (10 papers), Viral Infectious Diseases and Gene Expression in Insects (8 papers), Protein Kinase Regulation and GTPase Signaling (6 papers) and Glycosylation and Glycoproteins Research (5 papers). The work is most often cited by research in Immunology and Allergy (811 citations), Oncology (3.1k citations), Molecular Biology (5.8k citations), Cancer Research (1.2k citations) and Cell Biology (1.1k citations). S A Aaronson has collaborated with scholars based in United States, Italy and Spain. Frequent co-authors include Adriana Albini, Martin Gr, Kozłowski Jm, Yukihide Iwamoto, Kleinman Hk, M H Kraus, Andrew M. Chan, Timothy P. Fleming, Pier Paolo Di Fiore and Donald P. Bottaro. Their work appears in journals such as Proceedings of the National Academy of Sciences, Molecular and Cellular Biology, Journal of Virology, Journal of Biological Chemistry and Blood.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact